13.35% | % of shares held by all insiders |
97.36% | % of shares held by institutions |
112.36% | % of float held by institutions |
199 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Paradigm Biocapital Advisors LP | 2,389,902 | 30 Mar 2024 | 9.67% | 87,135,824 |
Atlas Venture Life Science Advisors, LLC | 2,287,233 | 30 Mar 2024 | 9.25% | 83,392,513 |
Orbimed Advisors LLC. | 1,702,237 | 30 Mar 2024 | 6.89% | 62,063,559 |
Bain Capital Life Sciences Investors, LLC | 1,317,213 | 30 Mar 2024 | 5.33% | 48,025,584 |
State Street Corporation | 1,091,211 | 30 Mar 2024 | 4.41% | 39,785,552 |
Price (T.Rowe) Associates Inc | 944,213 | 30 Mar 2024 | 3.82% | 34,426,005 |
Perceptive Advisors Llc | 939,866 | 30 Mar 2024 | 3.80% | 34,267,513 |
Blackrock Inc. | 901,595 | 30 Mar 2024 | 3.65% | 32,872,152 |
Frazier Life Sciences Management, L.P. | 785,000 | 30 Mar 2024 | 3.18% | 28,621,099 |
Vanguard Group Inc | 782,751 | 30 Mar 2024 | 3.17% | 28,539,100 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 798,635 | 29 Apr 2024 | 3.23% | 29,118,231 |
Vanguard Total Stock Market Index Fund | 455,540 | 30 Mar 2024 | 1.84% | 16,608,987 |
Price (T.Rowe) New Horizons Fund | 453,611 | 30 Mar 2024 | 1.83% | 16,538,656 |
Fidelity Select Portfolios - Biotechnology | 393,679 | 29 Apr 2024 | 1.59% | 14,353,535 |
iShares Russell 2000 ETF | 225,890 | 29 Apr 2024 | 0.91% | 8,235,949 |
Vanguard Extended Market Index Fund | 185,669 | 30 Mar 2024 | 0.75% | 6,769,491 |
Janus Henderson Global Life Sciences Fund | 126,306 | 30 Mar 2024 | 0.51% | 4,605,116 |
Fidelity Small Cap Index Fund | 93,897 | 30 Mar 2024 | 0.38% | 3,423,484 |
iShares Biotechnology ETF | 92,241 | 29 Apr 2024 | 0.37% | 3,363,106 |
Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 80,364 | 29 Apr 2024 | 0.33% | 2,930,071 |